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Abstract
Background: In selected patients, total pancreatectomy with islet autotransplantation (TPIAT) effectively
relieves pain caused by chronic pancreatitis and ameliorates the brittle diabetes of the apancreatic state.
Patients often undergo multiple endoscopic and surgical interventions prior to TPIAT, increasing the risk
for pancreas colonization with enteric microorganisms. Little is known of the safety of transplanting islet
cells with microbial contamination.
Methods: A prospectively collected database of 80 patients submitted to TPIAT at the Medical Univer-
sity of South Carolina from March 2009 to February 2012 was retrospectively reviewed. Patient charts
were reviewed for postoperative infectious complications and organisms identified were compared with
those identified in pre-transplant islet cultures.
Results: A total of 35 patients (43.8%) had a positive pre-transplant islet cell Gram stain or islet cell
culture from the final islet preparation solution. Of these 35 patients, 33 (94.3%) were given antibiotics
prophylactically post-transplant for a positive islet Gram stain or culture. Twenty patients (57.1%) receiv-
ing Gram stain- or culture-positive islets developed postoperative infectious complications, but only four
patients (11.4%) developed infections that concorded with their pre-transplant islet product.
Conclusions: Islet transplant solutions are frequently culture-positive, presumably as a result of
prior pancreas intervention. Microbial contamination of islet preparations should not preclude
autotransplantation.
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Introduction
Chronic pancreatitis (CP) is marked by debilitating, recalcitrant
pain. The underlying pathophysiology of the severe pain of this
disease, however, is poorly understood, which makes therapeutic
decision making challenging. Frontline management is medical.
Endoscopic interventions are undertaken with the intent of reliev-
ing any obstructive component to the disease. Patients in whom
medical therapy fails may be selected for operative treatment with
ductal drainage and directed resectional procedures.1 In highly
selected patients in whom these lesser interventions have failed,
total pancreatectomy with islet autotransplantation (TPIAT) is
indicated for pain relief and to avoid the brittle diabetes of the
apancreatic state.2
Therefore, patients submitting to TPIAT have typically under-
gone multiple prior endoscopic interventions or surgeries prior to
TPIAT. Instrumentation of the pancreatic duct through the gas-
trointestinal tract and surgical anastomosis of the pancreas to the
gastrointestinal tract both result in contamination and coloniza-
tion of the pancreas with gastrointestinal bacterial flora.3
During TPIAT, the excised pancreas is dissected free from
adjoining fat, gut and large vessels. The pancreas is placed in a
balanced, chilled electrolyte solution (University of Wisconsin
solution) after pancreatic duct infusion with the solution. The
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prepared pancreas is transported in a cooled, sterile package to the
clean cell facility where the islets are separated from the exocrine
tissue of the gland. The islets are then transplanted into the liver
sinusoids through the portal vein infusion. The islets are washed
during the process, but bacterial contamination often persists. The
clinical consequence of the infusion of islets and potentially small
amounts of bacteria into the liver has not been well examined
previously.
The purpose of this study was to determine whether the trans-
plant of contaminated islet cells affects the postoperative infection
rate, and whether antibiotic prophylaxis makes a difference.
Materials and methods
Patient data collection
This study was conducted in strict adherence to the guidelines of
the Medical University of South Carolina (MUSC) Institutional
Review Board. A prospectively collected database of 84 patients
undergoing TPIAT at MUSC between March 2009 and February
2012 was retrospectively reviewed andmicrobiological data on the
islet cell product were evaluated. Patient charts were reviewed for
postoperative infectious complications and organisms identified
were compared with pre-transplant islet cultures. Data for four
patients were excluded from this study as islet product Gram stain
and/or culture information for these patients was incomplete.
This left 80 patients in the study group.
Operative procedure and antibiotic prophylaxis
All patients received one dose of prophylactic broad-spectrum
antibiotics (cefazolin 1 g and flagyl 500 mg, or cipro 400 mg with
flagyl 500 mg in the case of prior anaphylactic penicillin reac-
tions) in the preoperative period. The technique involves the
removal of the entire pancreas, as well as the spleen and duo-
denum. Completion pancreatectomy was performed in patients
who had undergone prior pancreatic surgery. Pancreas prepara-
tion is performed on the operating table and includes the removal
of debris and infusion of a cold balanced electrolyte solution
(University of Wisconsin solution) into the main pancreatic duct
prior to its transportation on ice to the clean room facility.
Islet cell processing
Once harvested, the pancreas is transported on ice to the clean
room area in an aseptic fashion. It is removed from the cooler and
weighed, after which it is cleaned and a digestive enzyme is
injected to initiate the islet cell extraction process. Once the pan-
creas is soft enough, it is diced into smaller pieces for further
processing. The diced remains are placed in a Ricordi digestion
chamber and begin the islet isolation procedure in a shaker arm
while passing through the inner chamber at a temperature of
37 °C to aid digestion. During this process, a sample is obtained
every 5 min via the isolation box tubing in order to determine
when the digestive process can be stopped. Once the process can
be stopped, the mixture is cooled at 10 °C to inhibit the digestive
enzymes. The mixture then flows from the isolation box to the
collection chamber and is centrifuged at 4 °C and sterilely washed
for 3 min to remove any remaining digestive enzyme. The wash
solution is sterilely removed and the cells sit inViaspan incubation
solution for 45 min. Following this period of ‘rest’, the cells are
washed and centrifuged once more before being resuspended in
albumin for final packaging and transport.
Fluid samples to be sent for clinical microbiology testing are
obtained from the final islet preparation solution as well as the
transport solutions and are incubated for approximately 5–7 days.
Sterility testing is performed in-house with thioglycollate broth
with an incubation period of 28 days as recommended in US Food
and Drug Administration (FDA) guidelines. There have been no
discrepancies between in-house sterility testing of solutions and
clinical microbiology culture results. Physicians are notified
immediately when an organism has been detected on culture
medium. Microorganisms present are typically detected within
12–18 h of incubation.
Islet cell autotransplantation
The intensive care unit is alerted approximately 1 h before the
finished islet product is expected to be ready in order to prepare
the patient for transport to the interventional radiology depart-
ment. In the interventional radiology suite, islet cells are intro-
duced percutaneously into the portal vein. Portal venous pressures
are measured before and after the infusion of islet cells. The access
tract is embolized with gelfoam after the procedure to provide
appropriate haemostasis.
Results
Two patients (5.7%) had a positive islet culture (Table 1) but did
not receive antibiotic prophylaxis postoperatively and, notably,
did not develop any postoperative infections. Thirty-five patients
(43.8%) had a positive pre-transplant islet cell Gram stain
(Table 2) or islet cell culture (Table 3) from the final islet prepa-
ration solution. Multiple organisms were noted to be present on
Gram stain and/or final culture results in several patients. Of the
35 patients, 33 (94.3%) were given antibiotics prophylactically
post-transplant for a positive islet Gram stain or culture. Twenty
patients (57.1%) receiving Gram stain- or culture-positive islets
developed postoperative infectious complications (Table 4), but
only four of these patients (11.4%) developed infections with
the organism cultured from their pre-transplant islet product
Table 1 Data on microbiological positivity in 80 patients and corre-
sponding use of antibiotics
Islet Gram stain/culture result n Patients receiving
antibiotics, n
Gram stain and culture negative 45 Not applicable
Gram stain positive 12 12
Culture positive 33 31
Gram stain or culture positive 35 33
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(Table 5). These infections comprised two mixed Gram-negative/
Gram-positive urinary tract infections, Staphylococcus aureus
pneumonia, and sepsis related to Enterococcus species. These four
patients were treated early with the appropriate antibiotics related
to the organism detected in their positive islet cultures. In this
series, 31 patients (88.6%) with positive pre-transplant Gram
stains or cultures did not develop infections related to their islet
cell culture. One patient with a negative Gram stain and islet
culture died as a result of multi-system organ failure.
In the 45 patients with both a negative islet Gram stain and a
negative islet cell culture, postoperative complications included
readmission for dehydration associated with nausea and emesis
(6.7%), intra-abdominal abscess requiring percutaneous drainage
(8.8%), reoperation for intra-abdominal bleeding (4.4%), and
readmission for pneumonia (4.4%), respiratory failure (4.4%)
and urinary tract infection (2.2%).
Discussion
Total pancreatectomy has received renewed interest in centres
worldwide as a method of alleviating pain and improving quality
of life in patients with CP in whom other options (endoscopic or
lesser surgical interventions) have failed.4–16 As prolonged CP can
lead to the destruction of islets for autotransplantation with risk
for beta cell apoptosis, early intervention with TPIAT has been
considered for better islet yields.16,17 Prior instrumentation poten-
tially leads to bacterial contamination of the pancreas. Prior
reports have demonstrated evidence of microbial contamination
in islet transport solutions.3,18,19 The pancreatic tissue is heavily
washed throughout the harvesting process and the final islet
preparation is mixed with antibiotic solution (cefazolin, 1 g) prior
to infusion. The potential for clinically significant resultant infec-
tion requires evaluation.
In the present review of 80 patients, 20 of 35 patients (57.1%)
with a positive Gram stain or culture developed postoperative
infections, four (11.4%) of which were in concordance with their
pre-transplant culture product. Two of these patients had urinary
tract infections with mixed organisms that were unlikely to be
related to the islet contaminant. Another had S. aureus pneumo-
nia, with a questionable clinical connection. The final patient
developed enterococcal bacteraemia, which potentially was related
to the islet infusion.All of these infectious complications were well
treated with directed antibiotic therapy. Although an additional
step of washing the islet cells is utilized during harvesting for islet
allotransplantation, it is not routinely used for autologous islet
processing. As the majority of postoperative infections are urinary
tract infections and unrelated to culture results, it seems that
islet preparations with bacterial contamination can be safely
autotransplanted without prohibitive risk for a serious infectious
complication. These results are similar to those found by Wray
et al. in a similar patient population undergoing autologous islet
autotransplantation.3
Table 2 All microorganisms identified from pre-transplant islet Gram
stain in 12 patients
Microorganism n
Gram-positive cocci 6
Yeast 3
Gram-negative rods 6
Enterococcus species 1
Escherichia coli 2
Klebsiella pneumoniae 1
Citrobacter freundii complex 1
Proteus vulgaris 1
Table 3 All microorganisms identified from pre-transplant islet
culture in 33 patients
Microorganism n
Enterococcus species 7
Klebsiella pneumoniae 6
Escherichia coli 3
Yeast 2
Candida glabrata 1
Alpha haemolytic streptococcus 1
Gram-negative 1
Enterobacter cloacae 2
Mixed Gram-negative and Gram-positive 5
Streptococcus agalactiae 1
Streptococcus species 1
Gram-positive cocci 3
Lactobacillus species 1
Klebsiella oxytoca 1
Serratia marcescens 1
Citrobacter koseri 1
Citrobacter freundii 1
Candida albicans 1
Table 4 Postoperative complications based on 20 patients with a
positive Gram stain or culture
Complication n
Urinary tract infection 14
Bacteraemia 7
Sepsis 1
Clostridium difficile infection 1
Pneumonia 1
Wound infection 3
Intra-abdominal abscess 3
Positive respiratory culture 2
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At the study institution, empiric practice has been to treat
patients with a positive islet culture for 3 days for the organism
isolated with the aim of prophylactically treating any infused bac-
terial load.As this practice was undertaken in most patients in this
series, the effect of this treatment cannot be properly examined
other than to note that it did not prevent infection in the four
patients in whom potentially related infections were observed.
The transplantation of contaminated islet cells has also been
reported in allotransplantation in a study using fresh cadaver
islets.20 One dose of prophylactic antibiotics was administered
prior to islet infusion. Two of the study patients received contami-
nated islets but did not develop an infectious postoperative com-
plication.20 However, a separate study reported two cases of
septicaemia that were likely to be related to the infusion of con-
taminated cryopreserved islets in a series in which prophylactic
antibiotics did not appear to be utilized prior to infusion.21 Com-
paring postoperative complications in patients who undergo
allotransplantation with outcomes in patients submitted to
autologous islet transplantation is difficult as the harvesting
process, reason for transplant and immunological status of the
patients differ vastly. More research is warranted in both areas
of transplantation before clear answers can be obtained and
compared.
The investigation of whether antibiotic prophylaxis in this
setting makes a difference to rates of postoperative infection
requires a control group. As all but two patients in the present
series received prophylactic antibiotics in the setting of a positive
islet Gram stain or culture, the present findings do not support
any comment on the utility of antibiotic prophylaxis in preventing
postoperative infections. Comparisons with a control group
would help to delineate whether antibiotic prophylaxis is benefi-
cial in this setting.
Conclusions
In patients undergoing TPIAT for CP, islet transplant solutions are
frequently culture-positive, most probably as a result of prior
pancreatic intervention. Although invasive infections correlating
with pre-transplant islet cultures do occasionally occur, microbial
contamination of islet preparations should not preclude
autotransplantation. The present authors are unable to draw con-
clusions on the utility of antibiotic prophylaxis in the setting of a
positive islet culture as such prophylaxis was routinely employed
and used in all but two patients in this study.
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